Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T

Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
Journal of Nuclear Medicine November 2023, 64 (11) 1765-1771; DOI: https://doi.org/10.2967/jnumed.123.265878
Amir Karimzadeh
1Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany;
2Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula Soeiro
3Centro Hospitalar Universitário de São João, Porto, Portugal;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benedikt Feuerecker
4Department of Radiology, University Hospital, LMU Munich, Munich, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte-Sophie Hecker
1Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karina Knorr
1Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias M. Heck
5Department of Urology, School of Medicine, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Tauber
5Department of Urology, School of Medicine, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Calogero D’Alessandria
1Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang A. Weber
1Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Eiber
1Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Rauscher
1Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 64 no. 11 1765-1771
DOI 
https://doi.org/10.2967/jnumed.123.265878
PubMed 
37678925

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication April 17, 2023
  • Revision received August 1, 2023
  • Published online November 2, 2023.

Article Versions

  • previous version (September 7, 2023 - 06:29).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Amir Karimzadeh1,2,
  2. Paula Soeiro3,
  3. Benedikt Feuerecker4,
  4. Charlotte-Sophie Hecker1,
  5. Karina Knorr1,
  6. Matthias M. Heck5,
  7. Robert Tauber5,
  8. Calogero D’Alessandria1,
  9. Wolfgang A. Weber1,
  10. Matthias Eiber*,1 and
  11. Isabel Rauscher*,1
  1. 1Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany;
  2. 2Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;
  3. 3Centro Hospitalar Universitário de São João, Porto, Portugal;
  4. 4Department of Radiology, University Hospital, LMU Munich, Munich, Germany; and
  5. 5Department of Urology, School of Medicine, Technical University of Munich, Munich, Germany
  1. For correspondence or reprints, contact Amir Karimzadeh (amir.karimzadeh{at}uke.de).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 2 Citations
  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Comment on: “Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta‑analysis”
    Jun Ma, Wei Han
    Targeted Oncology 2024 19 5
  • Organ and tumor dosimetry including method simplification for [177Lu]Lu-PSMA-I&T for treatment of metastatic castration resistant prostate cancer
    Amir Karimzadeh, Linus Schatz, Markus Sauer, Ivayla Apostolova, Ralph Buchert, Susanne Klutmann, Wencke Lehnert
    EJNMMI Physics 2024 11 1
  • First real-world clinical experience with [177Lu]Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer beyond VISION and TheraP criteria
    Sui wai Ling, Quido de Lussanet de la Sablonière, Michael Ananta, Erik de Blois, Stijn L. W. Koolen, Roosmarijn C. Drexhage, Johannes Hofland, Debbie G. J. Robbrecht, Astrid A M van der Veldt, Frederik A Verburg, Tessa Brabander
    European Journal of Nuclear Medicine and Molecular Imaging 2025 52 6

Article usage

Article usage: September 2023 to April 2025

AbstractFullPdf
Sep 202312185836
Oct 20233855118
Nov 2023544406127
Dec 2023909323
Jan 20248515837
Feb 20244223917
Mar 20243814945
Apr 20242213927
May 2024235724
Jun 20242513042
Jul 20241221733
Aug 20241120039
Sep 2024256945
Oct 2024255034
Nov 2024217352
Dec 2024105150
Jan 202584931
Feb 2025510346
Mar 202566135
Apr 2025185037
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (11)
Journal of Nuclear Medicine
Vol. 64, Issue 11
November 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber, Isabel Rauscher
Journal of Nuclear Medicine Nov 2023, 64 (11) 1765-1771; DOI: 10.2967/jnumed.123.265878

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber, Isabel Rauscher
Journal of Nuclear Medicine Nov 2023, 64 (11) 1765-1771; DOI: 10.2967/jnumed.123.265878
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • [18F]FDG PET/CT Predicts Patient Survival in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease
  • Whole-Body [18F]DPA-714 Kinetic Assessment Using PET/CT Scanner with Long Axial Field of View
  • Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience
Show more Clinical Investigation

Similar Articles

Keywords

  • prostate-specific membrane antigen radioligand therapy (PSMA RLT)
  • metastatic castration-resistant prostate cancer (mCRPC)
  • health-related quality of life (HRQoL)
  • EORTC QLQ-C30
SNMMI

© 2025 SNMMI

Powered by HighWire